We have also demonstrated that the expression of KIR2DL1 on CD8+ T cells was reduced in patients with RA compared to healthy subjects, and that the upregulation ofKIR2DL1, 2, and 3 by treatment with IL-2 was weaker in RApatients than in healthy subjects [9]. This evidence concerns the gene KIR2DL1 and rheumatoid arthritis.